Fosun Pharma USA Inc. is a wholly owned subsidiary of Fosun Pharma with a focus on building a fully integrated innovative biopharmaceutical company focused on the US market. With the backing of one of the strongest Pharma players in China, Fosun Pharma USA is actively looking to partner with late development stage companies globally to build or support the US commercialization of product for unmet medical needs.
Innovative R&D is the core driver
for sustainable growth of Fosun Pharma USA Inc.
A leading player in specialty generics and high barrier, complex and innovative 505b(2) products
We are now looking for late development stage (phase 2 and beyond) or commercial stage innovative products to in-license/partner or acquire for the USA market. While we can facilitate partnership with our parent company for the Chinese market, our clear focus is on US rights for innovative biopharmaceuticals.
104 Carnegie Center, Suite 204
Princeton, NJ 08540
(609) 250-2802
info.usa@fosunpharma.com
Customer Service & Adverse Event/ Quality Concerns: (855) 282-4882 or fosuncs@eversana.com
© 2024 Fosun Pharma USA Inc. All rights reserved. | Privacy Notice
Fosun Pharma USA Inc., is committed to improving patients’ lives by bringing affordable and innovative medicines to the market. As such, Fosun Pharma USA Inc. neither condones nor supports the off-label use or misuse of its products. The use of our products for capital punishment, including by lethal injection, is contrary to our mission as well as the FDA-approved indications in our product labeling. Therefore, Fosun Pharma USA Inc., does not intentionally sell nor does it agree to the sale of its products, whether by our wholesalers, distributors or other customers, to correctional facilities, departments of correction, or any actor working in concert with them to purchase or secure our products.
